Sandra Mendoza Selected Research

Temozolomide (Temodar)

1/2013

Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Mendoza Research Topics

Disease

2	Major Depressive Disorder (Major Depressive Disorders) 08/2010 - 02/2010
1	COVID-19 01/2022
1	Lung Neoplasms (Lung Cancer) 04/2018
1	Neoplasms (Cancer) 04/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Carcinogenesis 06/2015
1	Callosities 06/2015
1	Adenocarcinoma 06/2015
1	Hyponatremia 01/2013
1	Hypersensitivity (Allergy) 01/2013
1	Melanoma (Melanoma, Malignant) 01/2013
1	Neutropenia 01/2013
1	Thrombocytopenia (Thrombopenia) 01/2013
1	Renal Insufficiency (Renal Failure) 01/2013
1	Familial Dysautonomia (Riley Day Syndrome) 11/2011

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 04/2018 - 11/2011
2	Biomarkers (Surrogate Marker)IBA 04/2018 - 01/2018
2	EnzymesIBA 06/2015 - 02/2010
1	Thyroid Nuclear Factor 1IBA 04/2018
1	GlucuronidaseIBA 06/2015
1	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 06/2015
1	Anticarcinogenic AgentsIBA 06/2015
1	Dimenhydrinate (DMH)FDA LinkGeneric 06/2015
1	CateninsIBA 06/2015
1	130-nm albumin-bound paclitaxelIBA 01/2013
1	Albumin-Bound Paclitaxel FDA Link 01/2013
1	Temozolomide (Temodar)FDA LinkGeneric 01/2013
1	CreatinineIBA 01/2013
1	Dacarbazine (DIC)FDA LinkGeneric 01/2013
1	oblimersen (G3139)IBA 01/2013
1	Antisense OligonucleotidesIBA 01/2013
1	Messenger RNA (mRNA)IBA 11/2011
1	Phosphotransferases (Kinase)IBA 11/2011
1	KinetinIBA 11/2011
1	Biological ProductsIBA 08/2010
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2010
1	CytokinesIBA 02/2010

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2022 - 01/2013